252 Participants Needed

Dichoptic Treatment for Lazy Eye

(ATS24 Trial)

Recruiting at 40 trial locations
BP
RT
Overseen ByRaymond T Kraker, MSPH
Age: < 18
Sex: Any
Trial Phase: Phase 3
Sponsor: Jaeb Center for Health Research
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

Participants eligible for the study will be randomly allocated (1:1:1) to receive either Luminopia dichoptic treatment while wearing optical correction if needed, Vivid Vision dichoptic treatment while wearing optical correction if needed, or continued optical correction alone if needed, with clinical assessments at 9- and 18-weeks post-randomization. At the 18-week primary outcome visit, participants who were randomly assigned to receive optical correction alone if needed with an IOD of 1 logMAR line (5 letters) or more, will be offered randomization to Luminopia or Vivid Vision dichoptic therapy and if they accept, followed forward with visits at 27- and 36-weeks post-randomization. The study will end for all other participants at 18 weeks.

Will I have to stop taking my current medications?

The trial protocol does not specify if you need to stop taking your current medications, but it does require stopping cycloplegic eyedrops (like atropine) two weeks before joining the study.

What data supports the effectiveness of the treatment Luminopia One for lazy eye?

Research shows that dichoptic treatments like Luminopia One, which involve presenting different images to each eye, can improve visual acuity (sharpness of vision) and encourage better adherence in children with amblyopia (lazy eye). These treatments are more engaging for children, potentially leading to better compliance and outcomes compared to traditional methods.12345

Is dichoptic treatment for lazy eye safe for humans?

The research does not provide specific safety data for dichoptic treatments like Luminopia or Vivid Vision, but these treatments are generally designed to be non-invasive and involve using video games or movies to improve vision, which suggests they are likely safe for human use.12367

How is the dichoptic treatment for lazy eye different from other treatments?

The dichoptic treatment for lazy eye, like Luminopia and Vivid Vision, is unique because it uses therapeutic modifications to streaming content or movies to balance visual input from each eye, making it more engaging and potentially improving adherence compared to traditional methods like eye patches or blurring drops.238910

Research Team

BG

Benajmin G Jastrzembski, MD

Principal Investigator

University of California, Davis

MT

Marjean T Kulp, OD

Principal Investigator

Ohio State University

Eligibility Criteria

This trial is for children aged 8 to less than 13 with lazy eye (amblyopia) ranging from mild to severe (20/40 to 20/200 vision). They must have a significant difference in vision between eyes and may have associated conditions like strabismus or anisometropia. Kids with very slight eye alignment issues are included, but those with more serious unrelated health problems cannot participate.

Inclusion Criteria

I am between 8 and 12 years old.
I have lazy eye due to crossed eyes, different eye prescriptions, or both.
Refractive correction required for specific refractive errors
See 11 more

Exclusion Criteria

Myopia greater than -6.00D spherical equivalent in either eye
I have an eye condition that could affect my vision.
I have experienced double vision more than once in the past week.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Luminopia dichoptic treatment, Vivid Vision dichoptic treatment, or continued optical correction alone, with clinical assessments at 9- and 18-weeks post-randomization

18 weeks
2 visits (in-person) at 9 and 18 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Optional Extension

Participants initially receiving optical correction alone with an IOD of 1 logMAR line or more may opt into further dichoptic therapy and are followed with visits at 27- and 36-weeks post-randomization

18 weeks
2 visits (in-person) at 27 and 36 weeks

Treatment Details

Interventions

  • Luminopia
  • Vivid Vision
Trial OverviewThe study tests two treatments for lazy eye: Luminopia and Vivid Vision, both used alongside regular glasses if needed. It compares these therapies against just using glasses alone. Children will be randomly assigned to one of the three groups and evaluated at weeks 9 and 18, with some continuing until week 36.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Vivid Vision GroupExperimental Treatment1 Intervention
dichoptic games using the Vivid Vision headset, prescribed approximately 25 minutes per day (treatment time to complete the day's sessions can be split into shorter sessions totaling about 25 minutes each day) 6 days per week with current optical correction if needed
Group II: Luminopia GroupExperimental Treatment1 Intervention
dichoptic movies/shows wearing the Luminopia headset prescribed 1 hour per day (treatment time can be split into shorter sessions totaling 1 hour each day) 6 days a week with current optical correction if needed
Group III: Continued Optical Correction GroupActive Control1 Intervention
continued full-time optical correction alone if needed

Luminopia is already approved in United States for the following indications:

🇺🇸
Approved in United States as Luminopia One for:
  • Amblyopia
  • Intermittent Exotropia

Find a Clinic Near You

Who Is Running the Clinical Trial?

Jaeb Center for Health Research

Lead Sponsor

Trials
162
Recruited
36,200+

Pediatric Eye Disease Investigator Group

Collaborator

Trials
20
Recruited
4,800+

National Eye Institute (NEI)

Collaborator

Trials
572
Recruited
1,320,000+

Findings from Research

In a study involving 182 children aged 4 to 6 years with amblyopia, the use of a binocular iPad game, Dig Rush, resulted in a greater improvement in amblyopic-eye visual acuity after 4 weeks compared to continued spectacle correction alone, with an adjusted difference of 0.5 logMAR lines.
After 8 weeks, the improvement in visual acuity was not significantly different between the two groups, suggesting that while the binocular treatment shows promise, further modifications may be needed to enhance its long-term efficacy.
A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 4 to 6 Years.Manny, RE., Holmes, JM., Kraker, RT., et al.[2023]
Current treatments for amblyopia, like occlusion and pharmacological blurring, have limited success, with less than two-thirds of children achieving good visual acuity in the affected eye.
There is a lack of randomized controlled trials (RCTs) on new binocular treatments for amblyopia, but non-controlled studies show promise, indicating a need for further research to establish their safety and effectiveness.
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.Tailor, V., Bossi, M., Bunce, C., et al.[2022]
In a study involving 90 children aged 4-12 with amblyopia, the dichoptic treatment Luminopia One led to significant improvements in visual acuity, with best-corrected visual acuity (BCVA) improving from 0.50 logMAR to 0.35 logMAR after 12 weeks (P < 0.0001).
The treatment also showed high adherence rates, with a median adherence of 86%, indicating that children were able to consistently engage with the therapy over the 12-week period.
Digital therapeutic improves visual acuity and encourages high adherence in amblyopic children in open-label pilot study.Xiao, S., Gaier, ED., Wu, HC., et al.[2021]

References

A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 4 to 6 Years. [2023]
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years. [2022]
Digital therapeutic improves visual acuity and encourages high adherence in amblyopic children in open-label pilot study. [2021]
Active vision therapy for pseudophakic amblyopia. [2019]
5.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Use of liquid crystal eyeglasses for examination and recovery of binocular vision]. [2008]
Smartphone Applications for Amblyopia Treatment: A Review of Current Apps and Professional Involvement. [2019]
Stereoacuity Improvement using Random-Dot Video Games. [2020]
Binocular amblyopia treatment with contrast-rebalanced movies. [2020]
Binocular iPad treatment for amblyopia in preschool children. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Nonsurgical management of diplopia. [2019]